These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 31307256)

  • 1. Prolonged clinical remission and low disease activity statuses are associated with better quality of life in systemic lupus erythematosus.
    Poomsalood N; Narongroeknawin P; Chaiamnuay S; Asavatanabodee P; Pakchotanon R
    Lupus; 2019 Sep; 28(10):1189-1196. PubMed ID: 31307256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study.
    Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
    Arthritis Res Ther; 2020 Jan; 22(1):8. PubMed ID: 31924267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus.
    Jiang HZ; Lin ZG; Li HJ; -Du Q; -Tian W; Wang SY; Guan SQ; Mei YF
    Clin Rheumatol; 2018 Jan; 37(1):151-160. PubMed ID: 29168029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus.
    Tselios K; Gladman DD; Touma Z; Su J; Anderson N; Urowitz MB
    Arthritis Care Res (Hoboken); 2019 Jun; 71(6):822-828. PubMed ID: 30055090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and the associated factors of the Malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (SLEQoL and LupusQoL).
    Ahmad Pouzi NA; Shaharir SS; Mohd Tamil A; Mustafar R; Ahmad Maulana S; Mageswaren E; Wan Ghazali WS
    PLoS One; 2023; 18(5):e0285461. PubMed ID: 37186611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
    Ugarte-Gil MF; Hanly J; Urowitz M; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Clarke AE; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian K; Jacobsen S; Peschken C; Kamen DL; Askanase A; Pons-Estel BA; Alarcón GS
    Ann Rheum Dis; 2022 Nov; 81(11):1541-1548. PubMed ID: 35944946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of belimumab therapy on the quality of life in patients with systemic lupus erythematosus: A cohort study.
    Prete M; Susca N; Leone P; De Giacomo A; Bray A; Brunori G; Favoino E; Perosa F; Racanelli V
    Lupus; 2023 Nov; 32(13):1528-1535. PubMed ID: 37903488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cosmetic camouflage improves health-related quality of life in women with systemic lupus erythematosus and permanent skin damage: A controlled intervention study.
    Oliveira FAP; Santos FMMD; Dias AFMP; Neiva CLS; Telles RW; Lanna CCD
    Lupus; 2020 Oct; 29(11):1438-1448. PubMed ID: 32757736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Lupus Erythematosus Disease Activity Score Remission and Low Disease Activity States Discriminate Drug From Placebo and Better Health-Related Quality of Life.
    Jesus D; Henriques C; Matos A; Doria A; Inês LS
    Arthritis Care Res (Hoboken); 2024 Jun; 76(6):788-795. PubMed ID: 38258369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better Health-Related Quality of Life in Systemic Lupus Erythematosus Predicted by Low Disease Activity State/Remission: Data From the Peruvian Almenara Lupus Cohort.
    Ugarte-Gil MF; Gamboa-Cárdenas RV; Reátegui-Sokolova C; Medina-Chinchón M; Zevallos F; Elera-Fitzcarrald C; Pimentel-Quiroz V; Cucho-Venegas JM; Rodríguez-Bellido Z; Pastor-Asurza CA; Alarcón GS; Perich-Campos R
    Arthritis Care Res (Hoboken); 2020 Aug; 72(8):1159-1162. PubMed ID: 31199590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.
    Ugarte-Gil MF; Wojdyla D; Pons-Estel GJ; Quintana R; Gómez-Puerta JA; Catoggio LJ; Alvarellos A; Saurit V; Borba E; Sato E; Costallat L; Da Silva NA; Iglesias-Gamarra A; Neira O; Reyes-Llerena G; Cardiel MH; Amigo MC; Acevedo-Vásquez E; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA
    J Rheumatol; 2019 Oct; 46(10):1299-1308. PubMed ID: 30824636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between physicians' global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: A longitudinal study.
    Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
    Lupus; 2021 Sep; 30(10):1586-1595. PubMed ID: 34192957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining Low Disease Activity in Systemic Lupus Erythematosus.
    Polachek A; Gladman DD; Su J; Urowitz MB
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):997-1003. PubMed ID: 27696791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cutaneous disease activity in early lupus and its correlation with quality of life: a cross-sectional study.
    Hinduja N; Mv P; Padhee S; Maikap D; Padhan P; Kar HK; Misra R; Srinivas CR; Ahmed S
    Rheumatol Int; 2023 Oct; 43(10):1835-1840. PubMed ID: 37310437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosus.
    Thibault T; Rajillah A; Bourredjem A; Corneloup M; Maurier F; Wahl D; Muller G; Aumaitre O; Sève P; Blaison G; Besancenot JF; Martin T; Magy-Bertrand N; Samson M; Arnaud L; Amoura Z; Devilliers H;
    Rheumatology (Oxford); 2024 May; 63(5):1447-1455. PubMed ID: 37589711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus.
    Elera-Fitzcarrald C; Alva M; Gamboa-Cardenas R; Mora-Trujillo CS; Zevallos F; García-Poma A; Medina M; Rodriguez-Bellido Z; Perich-Campos RA; Pastor-Asurza CA; Segami MI; Ugarte-Gil MF
    Lupus; 2018 May; 27(6):913-919. PubMed ID: 29301472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting.
    Gatto M; Saccon F; Zen M; Regola F; Fredi M; Andreoli L; Tincani A; Urban ML; Emmi G; Ceccarelli F; Conti F; Bortoluzzi A; Govoni M; Tani C; Mosca M; Ubiali T; Gerosa M; Bozzolo E; Canti V; Cardinaletti P; Gabrielli A; Tanti G; Gremese E; De Marchi G; De Vita S; Fasano S; Ciccia F; Pazzola G; Salvarani C; Negrini S; Puppo F; Di Matteo A; De Angelis R; Orsolini G; Rossini M; Faggioli P; Laria A; Piga M; Mathieu A; Scarpato S; Rossi FW; de Paulis A; Brunetta E; Ceribelli A; Selmi C; Prete M; Racanelli V; Vacca A; Bartoloni E; Gerli R; Larosa M; Iaccarino L; Doria A
    Arthritis Rheumatol; 2020 Aug; 72(8):1314-1324. PubMed ID: 32275125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Aerobic Capacity and Quality of Life in Physically Inactive Patients With Systemic Lupus Erythematosus With Mild or Inactive Disease.
    Pinto AJ; Miyake CN; Benatti FB; Silva CA; Sallum AM; Borba E; de Sá-Pinto AL; Bonfá E; Gualano B
    Arthritis Care Res (Hoboken); 2016 Dec; 68(12):1780-1786. PubMed ID: 27058995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.
    Pimentel-Quiroz VR; Ugarte-Gil MF; Harvey GB; Wojdyla D; Pons-Estel GJ; Quintana R; Esposto A; García MA; Catoggio LJ; Cardiel MH; Barile LA; Amigo MC; Sato EI; Bonfa E; Borba E; Lavras Costallat LT; Neira OJ; Massardo L; Guibert-Toledano M; Chacón-Díaz R; Alarcón GS; Pons-Estel BA
    Lupus; 2019 Aug; 28(9):1101-1110. PubMed ID: 31291843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of disease activity patterns on health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE).
    Elefante E; Gualtieri L; Schilirò D; Stagnaro C; Signorini V; Zucchi D; Cardelli C; Carli L; Ferro F; Tani C; Mosca M
    Lupus Sci Med; 2024 Jul; 11(2):. PubMed ID: 39074950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.